Ibaraki, Japan

Shunji Nagahara


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Osaka, JP (2006)
  • Ibaraki, JP (2014)

Company Filing History:


Years Active: 2006-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shunji Nagahara: Innovator in Nucleic Acid Transfer and Gene Therapy

Introduction

Shunji Nagahara, an accomplished inventor based in Ibaraki, Japan, has made significant contributions to the fields of gene therapy and nucleic acid transfer. With two notable patents to his name, his innovative methodologies are paving the way for advancements in genetic medicine.

Latest Patents

Nagahara's latest patents focus on the efficient transfer of nucleic acids and the stability of gene therapy formulations. One of his patents, titled "Method of promoting nucleic acid transfer," introduces a method that utilizes a complex comprising a collagen or a collagen derivative along with a desired nucleic acid to enhance the transfer efficiency into cells. His other patent, "Stable gene preparations," addresses the need for stability in gene therapy formulations by incorporating at least one saccharide, non-hydrophobic amino acid, or an organic acid with two or more carboxyl groups, along with collagen or gelatin and an amino acid into the gene formulations.

Career Highlights

Throughout his illustrious career, Nagahara has been associated with notable companies such as Koken Company, Limited and Sumitomo Pharmaceuticals Company Limited. His work in these firms has further established him as a key player in his field, particularly in the integration of innovative practices in biotechnology.

Collaborations

Shunji Nagahara has collaborated with talented individuals like Masaaki Terada and Takahiro Ochiya, contributing to the advancement of his research and the successful implementation of his inventions. These collaborations have been instrumental in refining his innovative methods and increasing their applicability in the medical field.

Conclusion

As an inventor, Shunji Nagahara’s work is crucial in the landscape of gene therapy and nucleic acid transfer. His innovative patents and collaborations highlight his commitment to advancing medical science. With a focus on stability and efficiency, his contributions continue to influence the future of genetic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…